Our Recommendations
- Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika (2023)
- Prise en charge d’une épidémie de choléra (2018)
- Management of a cholera epidemic (Arabic) (2017)
- Handbook For Clinical Management Of Dengue (2012)
- Manuel pour les soins et la prise en charge des patients dans les centres de soins communautaires (2015)
New Publications
- Revised National Guidelines on Mpox (2024)
- Considerations for wastewater and environmental surveillance for monkeypox virus: interim guidance, 25 November 2024 (2024)
- Multi-country outbreak of mpox, External situation report #42- 9 November 2024 (2024)
- Considerations for border health and points of entry for mpox: interim guidance (2024)
- Issue Brief: Mpox Update (2024)
Filter
124
Featured
Recommendations
26
New Publications
30
Language
Document type
No document type
54
Guidelines
37
Studies & Reports
12
Fact sheets
8
Resource Platforms
6
Training Material
3
Infographics
2
Manuals
1
Online Courses
1
Countries / Regions
Nigeria
6
Guinea
4
Germany
4
Sierra Leone
3
Congo, Democratic Republic of
3
Brazil
3
Liberia
3
Madagascar
3
Senegal
2
Burkina Faso
2
Côte d’Ivoire / Ivory Coast
2
South Africa
2
Rwanda
1
Peru
1
Mozambique
1
Global
1
Dominican Republic
1
Paraguay
1
United Kingdom
1
Mali
1
Angola
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
65
Countries
8
Pharmacy & Technologies
6
Key Resources
4
Women & Child Health
3
Public Health
2
WHO Zika Virus Fact Sheet (Portuguese)
Updated: January 2016
Interim guidelines developed by CDC for healthcare providers in the United States caring for infants born to mothers who while pregnant traveled to or resided in an area with Zika virus transmission. These guidelines include recommendations for the evaluation, testing, and management of infants with...
Hoja informativa sobre el virus Zika que contiene recomendaciones para las mujeres embarazadas e información para el tratamiento, prevención y control de la enfermedad. Esta hoja también está disponible en inglés, portugués y francés !
El propósito de este documento es brindar a los profesionales de salud que asisten a mujeres gestantes, información actualizada en base a las mejores evidencias disponibles para prevenir la infección, diagnosticarla oportunamente, sugerir tratamiento, dar seguimiento a las embarazadas, así c...
This algorithm is addressed to laboratories
with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp...
July 2016
WHO Secretariat Information paper July 2016
Please download directly form the website. Large File 29 MB!
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...
This manual provides guidance on best practices to be followed in Ebola Care Units (ECUs)/Community Care Centres (CCCs). It is intended for health aid workers (including junior nurses and community health-care workers) and others providing care for patients in ECUs/CCCs. While the focus is on the ca...
Manuel pour les soins et la prise en charge des patients dans les centres de soins communautaires
recommended
Guide d’urgence provisoire
Recommandations francaises pour la prise enc harge du chikungunya
Médecine e tmaladies infectieuses 45(2015)243–263
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
